According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -69,16ย โฌ. In 2023 the company made an earnings per share (EPS) of -47,06ย โฌ a decrease over its 2022 EPS that were of -23,71ย โฌ.